pharmaceutical costs | The Lund Report

Nosse and Steiner Hayward Back Mandatory Rebates for High-Cost Drugs

The Oregon Department of Consumer and Business Services would step in if a drug exceeded $10,000 or had cost increases greater than 3.4 percent. State regulators would index a price according to what other countries have negotiated for the drugs. Consumers would also see a cap on costs that they pay out-of-pocket.

Rep. Rob Nosse, D-Portland, touted his aggressive and innovative approach to tackling uncontrolled pharmaceutical costs on Thursday, calling on Oregon to lead where Congress has failed and other state-based reforms have fallen short.

By:

Chris Gray

As Prescription Drug Costs Climb, Solutions Remain Evasive

Oregon Health Forum panelists discuss financial limits, transparency rules and the risk of stifling innovation in an effort to rein in prescription prices

Prescription drug costs are rising so fast that sick patients, pharmacists and health insurers can’t keep up, panelists said Wednesday morning in a lively discussion hosted by the Oregon Health Forum on “What’s Going on with Pharmaceutical Costs?”

By:

Courtney Sherwood

Pharmaceuticals Outpace Hospital Costs at CCOs

Learn what can be done to combat those price increases by attending our Nov. 2 breakfast forum.

The state’s 16 coordinated care organizations are experiencing an escalation in pharmaceutical prices, which are outpacing hospital charges at some CCOs, according to Dr. Jim Rickards, chief medical officer of the Oregon Health Authority.

By:

Diane Lund-Muzikant

PhRMA Representative Joins Breakfast Forum on Rising Drug Costs

Oregon Health Forum explores this timely issue at its breakfast forum on November 2.

High-cost specialty drugs have begun outpacing hospital expenditures, and public officials, lawmakers and consumer advocates are hard at work trying to figure out how to get a handle on this growing problem.

By:

Diane Lund-Muzikant

OHSU Reform Experts Weigh in on Affordable Care Act

The Affordable Care Act was expected to revolutionize healthcare in the US. But is access to healthcare easier? Have costs gone up or down? A Portland City Club forum puts tough questions to Oregon Health & Science University professors.

Healthcare is a $3 trillion industry in the U.S. with one out of every $5 passing through the hands of someone working in the industry, Dr. Samuel Metz of Physicians for a National Health Program, told a City Club audience Monday night.

By:

Jan Johnson

The Cost of a Cure

Advances in medicine provide cures and life sustaining treatment for tens of thousands of Oregonians. But who decides which patients will receive them? Is the life of a private insurance patient worth more than someone the Oregon Health Plan?

OPINION -- Dr.

By:

BJ Cavnor